Cyclosporine A- and FK506-induced apoptosis in PC12 cells

Cell Biology and Toxicology

Volumn 23, Issue 5, 2007, Pages 355-360

  Takadera, T ^a   Sakamoto, Y ^a   Hizume, Y ^a   Ohyashiki, T ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Cyclosporine A; FK506; Glycogen synthase kinase 3; PC12 cells

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ALSTERPAULLONE; CASPASE 3; CYCLOSPORIN A; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; NERVE GROWTH FACTOR; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SIZE; CELL STRAIN; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FRAGMENTATION REACTION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BENZAZEPINES; CASPASE 3; CYCLOSPORINE; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; IMMUNOSUPPRESSIVE AGENTS; INDOLES; MALEIMIDES; NERVE GROWTH FACTOR; PC12 CELLS; RATS; TACROLIMUS;

EID: 34250346368     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-007-0192-7     Document Type: Article

References (20)

1. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
2. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-9.
3. Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;45:953-1040.
4. Gao JX, Zhou YQ, Zhang RH, Ma XL, Liu KJ. Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine. Sheng Li Xue Bao. 2005;57:755-60.
5. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976;73:2424-8.
6. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65:391-426.
7. Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci. 2000;20:2567-74.
8. Jope RS, Johnson VW. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29:95-102.
9. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987;20:83-90.
10. Leost M, Schultz C, Link A, et al. Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur J Biochem. 2000;267:5983-94.
11. Linseman DA, Butts BD, Precht TA, et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci. 2004;24:9993-10002.
12. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
13. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 1998;273:19929-32.
14. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13:136-42.
15. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989;2:1000-4.
16. Takadera T, Ohyashiki T. Apoptotic cell death and caspase 3 (CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells. Eur J Biochem. 1997;249:8-12.
17. Takadera T, Sakamoto Y, Ohyashiki T. NMDA receptor 2B-selective antagonist ifenprodil-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons. Brain Res. 2004;1020:196-203.
18. Taylor AL, Watson CJE, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56:23-46.
19. Wang Y, Xie WY, He Y, et al. Role of CDK5 in neuroprotection from serum deprivation by μ-opioid receptor agonist. Exp Neurol. 2006;202:313-23.
20. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267:2003-6.